These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18220556)

  • 21. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues.
    Pavek P; Dvorak Z
    Curr Drug Metab; 2008 Feb; 9(2):129-43. PubMed ID: 18288955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of xenobiotic enzymes in human skin in vitro models to activate pro-sensitizers.
    Jäckh C; Fabian E; van Ravenzwaay B; Landsiedel R
    J Immunotoxicol; 2012; 9(4):426-38. PubMed ID: 22471730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of a systems biology approach to skin allergy risk assessment.
    Maxwell G; Mackay C
    Altern Lab Anim; 2008 Nov; 36(5):521-56. PubMed ID: 19025322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-dependent metabolism of xenobiotics.
    Mugford CA; Kedderis GL
    Drug Metab Rev; 1998 Aug; 30(3):441-98. PubMed ID: 9710703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to assess the mutagenic potential of cosmetic products without animal tests?
    Speit G
    Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a modified in vitro skin absorption method to study the epidermal/dermal disposition of a contact allergen in human skin.
    Pendlington RU; Minter HJ; Stupart L; MacKay C; Roper CS; Sanders DJ; Pease CK
    Cutan Ocul Toxicol; 2008; 27(4):283-94. PubMed ID: 19037761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of skin sensitisation potential.
    Roberts DW; Aptula AO
    J Appl Toxicol; 2008 Apr; 28(3):377-87. PubMed ID: 17703504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An activated sludge modeling framework for xenobiotic trace chemicals (ASM-X): assessment of diclofenac and carbamazepine.
    Plósz BG; Langford KH; Thomas KV
    Biotechnol Bioeng; 2012 Nov; 109(11):2757-69. PubMed ID: 22565415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating human interindividual biotransformation variance in health risk assessment.
    Lipscomb JC; Kedderis GL
    Sci Total Environ; 2002 Apr; 288(1-2):13-21. PubMed ID: 12013540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin metabolism phase I and phase II enzymes in native and reconstructed human skin: a short review.
    Kazem S; Linssen EC; Gibbs S
    Drug Discov Today; 2019 Sep; 24(9):1899-1910. PubMed ID: 31176740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competitive Biotransformation Among Phenolic Xenobiotic Mixtures: Underestimated Risks for Toxicity Assessment.
    Peng B; Liu M; Han Y; Wanjaya ER; Fang M
    Environ Sci Technol; 2019 Oct; 53(20):12081-12090. PubMed ID: 31532198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of genotoxicity information in the development of integrated testing strategies (ITS) for skin sensitization.
    Mekenyan O; Patlewicz G; Dimitrova G; Kuseva C; Todorov M; Stoeva S; Kotov S; Donner EM
    Chem Res Toxicol; 2010 Oct; 23(10):1519-40. PubMed ID: 20845941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simulation of chemical metabolism for fate and hazard assessment. I: approach for simulating metabolism.
    Dimitrov S; Pavlov T; Veith G; Mekenyan O
    SAR QSAR Environ Res; 2011 Oct; 22(7-8):699-718. PubMed ID: 21999104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous absorption and metabolism of [14C]-ethoxycoumarin in a pig ear skin model.
    Jacques C; Perdu E; Dorio C; Bacqueville D; Mavon A; Zalko D
    Toxicol In Vitro; 2010 Aug; 24(5):1426-34. PubMed ID: 20417268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated decision-tree testing strategy for skin sensitisation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2007 Dec; 35(6):683-97. PubMed ID: 18186673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational tools for modeling xenometabolism of the human gut microbiota.
    Klünemann M; Schmid M; Patil KR
    Trends Biotechnol; 2014 Mar; 32(3):157-65. PubMed ID: 24529988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.